Candesartan Cilexetil + Hydrochlorothiazide
Indications
Candesartan Cilexetil + Hydrochlorothiazide is used for:
Hypertension, Congestive heart failure
Adult Dose
Hypertension
16-32 mg candesartan/12.5-25 mg HCTZ PO: 1 tablet once daily.
Elderly: No dosage adjustment is necessary in elderly patients.
Impaired Hepatic Function: Patients with Hepatic Impairment: Dose titration is recommended in patients with mild to moderate chronic liver disease.
This should not be used in patients with severe hepatic impairment and/or cholestasis.
Child Dose
The safety and efficacy have not been established in children.
Renal Dose
Impaired Renal Function:
In patients with mild to moderate renal impairment (ie, creatinine clearance between 30-80 mL/min/1.73m2 BSA), a dose titration is recommended.
This should not be used in patients with severe renal impairment (creatinine clearance <30 mL/min/1.73 m2 BSA).
Administration
May be taken with or without food.
Contra Indications
Hypersensitivity.
Precautions
Volume or sodium depletion, preexisting renal insufficiency; aortic or mitral valve stenosis, hypertrophic obstructive cardiomyopathy, renal artery stenosis, primary hyperaldosteronism. Patients with a history of angioedema, urticaria. Monitor serum potassium levels especially in elderly and renally impaired patients. Hypotension may occur during major surgery and anaesthesia due to suppression of the renin-angiotensin system.
Lactation: enters breast milk/contraindicated
Pregnancy-Lactation
Pregnancy Category: C (1st trimester); D (2nd and 3rd trimesters)
Interactions
NSAIDs may reduce antihypertensive effect and result in deterioration of renal function including possible acute renal failure. May increase serum lithium concentration. K-sparing diuretics, K supplements or salt substitutes containing K may increase risk of hyperkalaemia.
Potentially Fatal: Coadministration w/ aliskiren in diabetic patients may increase risk of renal impairment, hypotension and hyperkalaemia.
Adverse Effects
Side effects of Candesartan Cilexetil + Hydrochlorothiazide :
1-10%
Headache (3%),Dizziness (3%),Upper respiratory tract infection (4%),Back pain (3%),Flu-like syndrome (2%)
Frequency Not Defined
Candesartan
Dizziness, headache, vertigo, back pain, upper resp tract infections, pharyngitis, rhinitis, hypotension, hyperkalaemia, increased serum creatinine.
Hydrochlorothiazide
Anorexia,Epigastric distress,Hypotension,Orthostatic hypotension,Photosensitivity,Anaphylaxis,Anemia,Confusion,Erythema multiforme,Stevens-Johnson syndrome,Exfoliative dermatitis including toxic epidermal necrolysis,Dizziness,Headache,Hyperuricemia,Hypokalemia and/or hypomagnesemia
Mechanism of Action
Candesartan inhibits the binding of angiotensin II to AT1 receptors in many tissues (e.g. vascular smooth muscles, adrenal gland) which leads to vasoconstriction blockade and aldosterone release.
Hydrochlorothiazide inhibits the reabsorption of Na and chloride in the distal tubules causing increased excretion of Na and water K and hydrogen ions.